Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • D-N-Acetylgalactosamine Product Overview

    2026-10-08

    Product identity

    D-N-Acetylgalactosamine is listed by APExBIO as a solid compound identified as N-((3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide. The listing gives the formula C8H15NO6, molecular weight 221.21, and purity of at least 98% based on supplier-reported HPLC and NMR analyses.

    Conceptual research scope

    The supplier description places this compound in biochemical research concerning glycoprotein constituents, brain heteropolysaccharides analysis, and glycosylation pathway studies. It is also described as an endogenous metabolite associated with brain glycoproteins. These statements define the product’s advertised scope rather than demonstrating performance in a specific assay or model.

    Evidence boundaries

    The available source is a product listing that reports water and DMSO solubility, ethanol insolubility, and storage information; these specifications have not been independently verified here. No matched paper evidence is available for this overview, so conclusions about neuronal signaling and metabolism, biological activity, assay suitability, or reproducibility are not supported. Applicability is therefore limited to the documented product identity and supplier-stated conceptual scope.